Oxford Nanopore files US subpoena application
Nanopore sequencing products company has filed an application in the US District Court for the Northern District of California for leave to serve subpoenas in support of a lawsuit it intends to file in the courts of England and Wales.
Oxford Nanopore said it filed an ex parte application that would allow it to serve Complete Genomics, Innomics, MGI Americas and others for breach of contractual obligations, claims for breach of common law obligations of confidence, breach of duties under the Trade Secrets Regulations 2018, and an entitlement claim to a license of certain patents.
Additionally, while not commenting on future litigation, Oxford Nanopore added that it does not believe BGI Tech Solutions' nanopore-based sequencing technology would be able to be used in commercial products around the world without infringing or misappropriating its own "substantial portfolio of proprietary rights".
As of 1005 BST, Oxford Nanopore shares were untraded at 144.10p.
Reporting by Iain Gilbert at Sharecast.com
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.